Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John P. Butler currently holds 3,367,064 shares of Zynerba Pharmaceuticals, Inc. (ZYNE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John P. Butler has been a net seller of ZYNE stock. They have purchased $571.3K and sold $733.8K worth of shares.
John P. Butler's most recent insider trade was on Mar 4, 2026, when they purchased 69,270 shares at $1.25 per share.
John P. Butler serves as Executive at Zynerba Pharmaceuticals, Inc. (ZYNE). They have executed 58 insider transactions totaling $1.3M over their tenure at the company.
John P. Butler holds the position of Executive at Zynerba Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
John P. Butler has shown a selling trading pattern, with $571.3K in total purchases and $733.8K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by John P. Butler was on Dec 12, 2018, when they sold $1.2M worth of AKBA shares. This transaction involved 135,697 shares at $8.94 per share.
John P. Butler currently owns 3,367,064 shares of Zynerba Pharmaceuticals, Inc. (ZYNE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John P. Butler's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John P. Butler has 58 Form 4 filings on record as an insider at Zynerba Pharmaceuticals, Inc..
Set alerts for John P. Butler and 40,000+ other insiders.